MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    What Non-Genetic Parkinson’s Disease Risk Factors are Africans Exposed To? A Scoping Review

    J. Lee, R. Mwezi, R. Morton, N. Fothergill-Misbah, C. Dotchin, R. Walker (United Kingdom)

    Objective: We set out to catalogue the risk factors patients with Parkinson’s Disease (PD) in Africa are exposed to. Background: Parkinson's disease (PD) is recognized…
  • 2026 International Congress

    Urate Levels and Risk of Parkinson’s Disease:A Two-Sample Mendelian Randomization Study

    P. Tang, Y. Liu (Xi'an, China)

    Objective: To investigate the causal relationship between circulating serum urate levels and the risk of Parkinson's disease (PD) using a two-sample Mendelian randomization (MR) approach.…
  • 2026 International Congress

    Mild Motor Impairments in Rapid Eye Movement Behavior Disorder: Tremor and Bradykinesia

    JH. Lee, ER. Tobin, EA. Christou, XY. Lou, M. Louis, LH. Le, MF. Presti, MS. Jaffee, DE. Vaillancourt (Gainesville, USA)

    Objective: We investigated patients with RBD to identify mild motor impairments through the objective quantification of sensitive motor control assays. Background: It is established that…
  • 2026 International Congress

    One day accelerated 10 Hz rTMS for Focal Hand Dystonia: A Phase II Clinical Trial

    I. Xu, Z. Simsek, P. Mulcahey, C. Bui, Y. Li, N. Hamzah, A. Norain, M. Lipp, D. Bitlis, S. Dave, K. Grozev, C. Russell, C. Petty, M. Lutz, A. Peterchev, N. Bukhari-Parlakturk (Durham, USA)

    Objective: To evaluate the efficacy of four sessions of 10 Hz repetitive transcranial magnetic stimulation delivered in one day (rTMS) to patients with focal hand…
  • 2026 International Congress

    The Correlation Between Serum Uric Acid Levels And The Severity Of Parkinson’s Disease

    D. Prihananti, E. Pasmanasari (Semarang, Indonesia)

    Objective: This study aims to analyze the correlation between serum uric acid levels and the severity of Parkinson's disease. Background: Uric acid has been implicated…
  • 2026 International Congress

    Beyond Parkinson’s Disease, Impulse Control Dysregulation: The Psychosocial Correlates of Problematic Internet Use

    T. Adeoye, O. Buhari, O. Adeoye (Ogbomoso, Nigeria)

    Objective: To determine the prevalence of problematic internet use and associated psychosocial correlates as a phenotype of impulse control dysregulation among undergraduates. Background: Impulse control…
  • 2026 International Congress

    Differential Oculomotor Patterns in Parkinson’s Disease and Multiple System Atrophy With Predominant Parkinsonism

    Y. Liu, P. Tang (Xi'an, China)

    Objective: To investigate the value of oculomotor function assessment in differentiating Parkinson’s disease (PD) from multiple system atrophy with predominant parkinsonism (MSA-P). Background: PD and MSA-P share…
  • 2026 International Congress

    Ulixacaltamide Demonstrates Superiority Over Placebo as Monotherapy and as Add-on to Propranolol in Essential Tremor: Phase 3 ESSENTIAL3 Study 1

    M. Souza, S. Petrou, M. Sniecinski, C. Santos, M. Giroux, M. Steidle, J. Farmer, S. Brillman, A. Shtilbans (Boston, USA)

    Objective: To evaluate efficacy of ulixacaltamide, a selective T-type calcium channel modulator, versus placebo in adults with essential tremor (ET) as monotherapy and as add-on…
  • 2026 International Congress

    Neuropsychiatric Symptoms in Lewy Body Disease: Monoaminergic Activity and Resting State Networks

    L. Wright, D. Burn, J. Taylor, J. O'Brien, A. Yarnall, M. Firbank, A. Thomas, R. Lawson (Newcastle, United Kingdom)

    Objective: Investigating how neuropsychiatric symptoms (NPS)—depression, anxiety, and apathy—relate to functional connectivity between monoaminergic nuclei and the limbic network (LN), default mode network (DMN), and…
  • 2026 International Congress

    Targeting c-Abl/Drp1-Dependent Mitochondrial Fission: Neuroprotective Effects of Berberine Chloride in Parkinson’s Disease Models

    D. Khatri (Chandwaji, Jaipur, India)

    Objective: To investigate the neuroprotective potential of berberine chloride in Parkinson’s disease (PD) by modulating pathological mitochondrial fission through c-Abl–mediated Drp1 phosphorylation using integrated bioinformatics,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley